EPISODE · Feb 17, 2026 · 13 MIN
Labcorp Q4 2025 Earnings Call and 2026 Outlook
from Daily Market Download · host Daily Market Download
These financial records detail Labcorp’s fiscal performance for 2025 and its strategic outlook for 2026. The company achieved significant revenue growth and expanded its specialty testing portfolio through 13 key acquisitions and partnerships. While earnings per share exceeded expectations, revenue slightly missed targets due to one-time issues with a large genetics client and weather disruptions. Management plans to invest in a massive new central laboratory facility to meet rising global demand. Looking ahead, the firm expects continued profitable growth driven by innovations in oncology and Alzheimer’s diagnostics. Final guidance suggests a positive long-term trajectory supported by disciplined capital allocation and operational efficiency.
What this episode covers
These financial records detail Labcorp’s fiscal performance for 2025 and its strategic outlook for 2026. The company achieved significant revenue growth and expanded its specialty testing portfolio through 13 key acquisitions and partnerships. While earnings per share exceeded expectations, revenue slightly missed targets due to one-time issues with a large genetics client and weather disruptions. Management plans to invest in a massive new central laboratory facility to meet rising global demand. Looking ahead, the firm expects continued profitable growth driven by innovations in oncology and Alzheimer’s diagnostics. Final guidance suggests a positive long-term trajectory supported by disciplined capital allocation and operational efficiency.
NOW PLAYING
Labcorp Q4 2025 Earnings Call and 2026 Outlook
No transcript for this episode yet
Similar Episodes
Jun 15, 2022 ·8m
May 25, 2022 ·20m
May 19, 2022 ·16m
May 15, 2022 ·34m
May 12, 2022 ·1m